Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-26-005409
Filing Date
2026-02-13
Accepted
2026-02-13 16:05:22
Documents
1
Period of Report
2026-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5805
  Complete submission text file 0001140361-26-005409.txt   7380
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O POSEIDA THERAPEUTICS 9390 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Rizvi Syed Ali-aamir (Reporting) CIK: 0001897621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 26632563